Articles tagged "Liver transplantation"

2019 American Transplant Congress
Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
M. Kosirog¹, P. T. Campbell¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern Medicine, Chicago, IL, ²Department of Preventive Medicine, Northwestern Medicine, Chicago, IL, ³Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁴Department of Pediatrics & Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁵Departments of Preventive Medicine and Medicine-Cardiology, Northwestern Medicine, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern Medicine, Chicago, IL
*Purpose: Tobacco use is a modifiable risk factor for major adverse cardiovascular events (MACE) in liver transplant recipients (LTRs). However, data are lacking about practitioner…
2019 American Transplant Congress
Meld Score / Grwr Ratio (meldgr) Can Predict Surgical Outcomes And Prognosis Of The Recipients In Adult-to-adult Living Donor Liver Transplantation
A. Tanemura, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji
Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Tsu, Japan
*Purpose: In living donor liver transplantation (LDLT), various risk factors have been identified among both recipient and donor factors, such as Model for End-Stage Liver…
2019 American Transplant Congress
Analysis Of Public Health Service Increased Risk Donors Shows No Viral Transmission In Liver Transplant Recipients And Similar Graft / Patient Survival When Compared To Non-increased Risk Donors
A. Amin, T. Ito, D. Ng, R. McMillan, J. DiNorcia, V. Agopian, F. Kaldas, H. Yersiz, R. Busuttil, D. Farmer
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Public Health Service increased risk donors (PHS-IRD) are underutilized in liver transplant (LT) due to concern for transmission of viral (HBV, HCV, and HIV)…
2019 American Transplant Congress
Short and Long Term Outcomes of Retrograde vs Antegrade Reperfusion of Liver Transplants. A Propensity Matched Pair Analysis
H. Sharma, B. Shrum, D. Quan, A. Skaro, W. Wall, V. McAlister.
Transplant Surgery, University of Western Ontario, London, ON, Canada
*Purpose: There are no published studies to compare long-term outcomes of retrograde-reperfusion-technique (RR) compared to antegrade-reperfusion-technique (AR) in liver-transplantation (LT). This retrospective-cohort-study compares short/long-term outcomes…
2019 American Transplant Congress
Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation
G. Kelly¹, J. L. Pasko¹, E. Dewey², E. Maynard¹, S. L. Orloff¹, C. Enestvedt¹
¹Division of Abdominal Transplant, OHSU, Portland, OR, ²Department of General Surgery, OHSU, Portland, OR
*Purpose: The aim of this study was to determine whether intraoperative autologous transfusion in liver transplant patients with HCC affects the rate of recurrence.*Methods: We…
2019 American Transplant Congress
Access to Deceased Donor Liver Transplant for Candidates in Hawaii and Puerto Rico
A. M. Robinson¹, I. K. Kim², A. K. Mathur³, S. E. Rosas⁴
¹United Network for Organ Sharing, Richmond, VA, ²Cedars-Sinai Medical Center, Los Angeles, CA, ³Mayo Clinic Arizona, Phoenix, AZ, ⁴Joslin Diabetes Center, Harvard Medical School, Boston, MA
*Purpose: Hawaii and Puerto Rico comprise their own donor service areas (DSAs), HIOP and PRLL respectively. The liver programs in these locations serve populations mostly…
2019 American Transplant Congress
Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation
S. Nagai¹, M. Rizzari¹, Y. Muszkat², K. Collins¹, A. Yoshida¹, S. Jafri², M. Abouljoud¹
¹Transplant and Hepatobiliary Surgeryery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: Liver-intestine allocation is determined in the liver waitlist. This study aimed to evaluate effects of recent updates in liver allocation policy on waitlist outcomes…
2019 American Transplant Congress
Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells
A. A. Duizendstra¹, R. J. Knegt de¹, M. G. Betjes², M. P. Peppelenbosch¹, N. H. Litjens², J. Kwekkeboom¹
¹Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands, ²Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands
*Purpose: Lifelong treatment with immunosuppressive drugs (IS) to prevent graft rejection in transplant recipients is accompanied by side effects. Some recipients are considered to be…
2019 American Transplant Congress
Frailty Associated with Increased Rates of Acute Cellular Rejection within 3 Months after Liver Transplantation
L. Fozouni, A. Lebsack, Y. Mohamad, C. Freise, P. Stock, J. Lai
UCSF, San Francisco, CA
*Purpose: Frailty, a state of decreased physiologic reserve and increased vulnerability to health stressors, has an inflammatory biologic basis and has been associated with dysregulation…
2019 American Transplant Congress
Variations in DCD Procurement Procedures across Opos and Their Effects on Liver Transplant Outcomes
A. P. Choubey¹, G. Mitro¹, E. J. Siskind², A. C. Ortiz³, M. Nayebpour⁴, N. Koizumi⁴, P. Wiederhold⁵, J. Ortiz¹
¹The University of Toledo, Toledo, OH, ²Inova Fairfax Hospital, Fairfax, VA, ³University of California, Los Angeles (UCLA), Los Angeles, CA, ⁴George Mason University, Fairfax, VA, ⁵Life Connection Of Ohio, Maumee, OH
*Purpose: Variations in procurement procedures across Organ Procurement Organizations (OPOs) may account for discrepancies in outcomes of donation after cardiac death (DCD) liver transplants. We…